NCT07226375

Brief Summary

The aim of the study is to compare the surgical tissue removal success of the endoscopic tissue cutting device, which was designed by the conductor and developed with the support of TUBITAK-1512 project and for which Turkish and European patent applications were made, with the conventional cold scalpel. Laparoscopic surgeries are performed through incisions ranging from 0.5 cm to 1 cm. After the operation, much larger masses need to be removed from the abdomen compared to these incisions. Currently, in laparoscopic surgery, masses are removed from the abdomen by cutting them into pieces with a scalpel, using electrical devices called power morcellators that are used to cut the tissue/mass with rotational movement and remove it from the abdomen, and directly removing the mass from the abdomen through an incision made as large as the size of the mass. Trying to remove large tissues/mass by dissecting them with a scalpel through incisions that are 1.5-2 cm wide and limit the surgeon's range of motion is quite laborious, tiring, time-consuming and risky. In the use of Power Morcellator disintegrator devices, there is a risk of the pieces of the mass spreading into the abdomen while cutting and separating the tissue/mass that is being removed into small pieces due to the rotational movement in the working principle. In operations where the Power Morcellator device is used, if the removed tissue is malignant (cancerous), the patient faces the risk of metastasis spreading to the entire abdomen. Due to these risks, the use of power morcellator devices has been completely banned in the United States, and in European Union countries, it has been required that the device be operated in protective bags. The invention is a medical device that will allow large masses to be removed quickly, safely and easily through small incisions in closed surgeries. The device offers an effective solution to the problems of the current technique. Within the scope of the study, the morcellator scissors and the scalpel, which are designed and started to be mass-produced, will be compared in the morcellation (removal by separating into pieces) process to be performed during the removal of the mass from the vagina after laparoscopic hysterectomy surgeries, and the morcellation time, possible complications and the possible effects of the device to be used on the case will be investigated.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Nov 2025Dec 2026

First Submitted

Initial submission to the registry

October 25, 2024

Completed
1 year until next milestone

First Posted

Study publicly available on registry

November 10, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

November 13, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 17, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2026

Last Updated

November 14, 2025

Status Verified

August 1, 2025

Enrollment Period

10 months

First QC Date

October 25, 2024

Last Update Submit

November 13, 2025

Conditions

Keywords

laparoscopic hysterectomymorcellationtissue extraction

Outcome Measures

Primary Outcomes (1)

  • Morcellation Time

    The time required for complete vaginal morcellation of the uterus, measured from the placement of the uterus into the retrieval bag until complete specimen removal. A shorter duration indicates higher procedural efficiency.

    From placement of uterus in retrieval bag to complete removal of specimen, measured in minutes (approximately 0-30 minutes).

Secondary Outcomes (1)

  • Change in Female Sexual Function Index (FSFI) Score

    Baseline (within 1 week before surgery) and 6 months after operation.

Study Arms (2)

Endoscopic Tissue Cutting and Abdominal Extraction Device

EXPERIMENTAL

In the cases included in the group, vaginal morcellation will be performed with an endoscopic tissue cutting and removal device after laparoscopic hysterectomy.

Device: Vaginal tissue morcellation with extraction device

Conventional Cold Scalpel

ACTIVE COMPARATOR

In the cases included in the group, vaginal morcellation will be performed with a cold scalpel after laparoscopic hysterectomy.

Device: Vaginal tissue morcellation with scalpel

Interventions

Vaginal tissue morcellation after laparoscopic hysterectomy with Endoscopic Tissue Cutting and Abdominal Extraction Device

Endoscopic Tissue Cutting and Abdominal Extraction Device

Vaginal tissue morcellation after laparoscopic hysterectomy with cold scalpel

Conventional Cold Scalpel

Eligibility Criteria

Age35 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Planned laparoscopic hysterectomy
  • Estimated uterine weight of 500 g or more

You may not qualify if:

  • Sexual inactivity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Bakircay University

Izmir, 35665, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Device Removal

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Central Study Contacts

Sabahattin A Arı, Associate Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 25, 2024

First Posted

November 10, 2025

Study Start

November 13, 2025

Primary Completion (Estimated)

September 17, 2026

Study Completion (Estimated)

December 17, 2026

Last Updated

November 14, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Data will not be shared at this stage to protect intellectual property rights related to the patented device. Deidentified data may be made available upon reasonable request after study completion

Locations